Cellosaurus cell line TUBO-P2J (CVCL

Cellosaurus TUBO-P2J (CVCL_2A34)

Cross-references
Cell line name	TUBO-P2J
Accession	CVCL_2A34
Resource Identification Initiative	To cite this cell line use: TUBO-P2J (RRID:CVCL_2A34)
Comments	Group: Patented cell line. Registration: International Depositary Authority, Korean Cell Line Research Foundation; KCLRF-BP-00272. Characteristics: Metastatic phenotype. Established from metastatic lung nodules in mice implanted with the parent cell line (PubMed=25179116). Genetic integration: Method=Transgenic mouse; Gene=RGD; 2561; Erbb2 (Note=With p.Val661Glu). Transformant: Activated Erbb2/neu. Derived from site: In situ; Mammary gland; UBERON=UBERON_0001911.
Disease	Malignant neoplasms of the mouse mammary gland (NCIt: C21678)
Species of origin	Mus musculus (Mouse) (NCBI Taxonomy: 10090) Breed/subspecies: BALB-neuT transgenic.
Hierarchy	Parent: CVCL_2A33 (TUBO [Mouse mammary tumor])
Sex of cell	Female
Age at sampling	Age unspecified
Category	Cancer cell line
Publications	Patent=KR101309902B1 SaeGwang Park, Su-Kil Seo, Sang Kyun Bae, Jae-Hyug Choi, Ha Na Jung, Jin-Hee Park, Tae Oh Kim, Sung Jae Park; Metastatic breast cancer cell line TUBO-P2J. Patent number KR101309902B1, 17-Sep-2013 PubMed=25179116; DOI=10.1186/1471-2407-14-647; PMCID=PMC4161915 Hyunkeun Song, Tae Oh Kim, Sun Young Ma, Jin-Hee Park, Jae-Hyug Choi, Jin-Ho Kim, Mi Seon Kang, Sang Kyun Bae, Ki Hyaung Kim, Tae Hyun Kim, Su-Kil Seo ...Show all 16 authors... , Il Whan Choi, Geun Am Song, Eric D. Mortenson, Yang-Xin Fu, SaeGwang Park; Show fewer authors Intratumoral heterogeneity impacts the response to anti-neu antibody therapy. BMC Cancer 14:647.1-647.12(2014)
Encyclopedic resources	Wikidata; Q54973346
Entry history
Entry creation	22-Sep-2015
Last entry update	19-Dec-2024
Version number	8